Jennifer Fitzpatrick
Known title: Chief Legal OfficerCIK: 0002061851
Associated companies
Transaction History
| SION | ▲ Buy | Grant | 28,132 | $0 | 9/17/2026 | View on chart |
| SION | ▲ Buy | Grant | 28,133 | $0 | 9/17/2026 | View on chart |
| SION | ▲ Buy | Option Exercise | 10,250 | $63K | 7/6/2026 | View on chart |
| SION | ▼ Sell | Open Market | 10,250 | $447K | 7/6/2026 | View on chart |
| SION | ▲ Buy | Option Exercise | 10,250 | $63K | 3/5/2026 | View on chart |
| SION | ▼ Sell | Open Market | 10,250 | $347K | 3/5/2026 | View on chart |
| SION | ▲ Buy | Option Exercise | 10,250 | $63K | 12/5/2025 | View on chart |
| SION | ▼ Sell | Open Market | 10,250 | $415K | 12/5/2025 | View on chart |
| SION | ▲ Buy | Option Exercise | 10,250 | $63K | 9/4/2025 | View on chart |
| SION | ▼ Sell | Open Market | 10,250 | $237K | 9/4/2025 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
Sionna Shares Fall 37.6% Over 4 Weeks, Trend Reversal Possible
Sionna Therapeutics shares fell 37.6% over the past four weeks. The drop has pushed the stock into a low RSI zone of 23.4, suggesting it may be oversold. The price is near a key support level at $5.71, which has been tested 20 times. Analysts see a potential trend reversal, but the stock remains far below its 52‑week high of $54.97.
Sionna Shares Fall 37.6% Over 4 Weeks, Trend Reversal Possible. Sionna Therapeutics shares fell 37.6% over the past four weeks. The drop has pushed the stock into a low RSI zone of 23.4, suggesting it may be oversold. The price is near a key support level at $5.71, which has been tested 20 times. Analysts see a potential trend reversal, but the stock remains far below its 52‑week high of $54.97.